Barry S Rodgers-Gray
10PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Apr 01, 2026
Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants.John Fullarton, Bosco Paes, Nicola Waghorne
|Jul 28, 2025
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce.Paolo Manzoni, Eugenio Baraldi, Fabio Midulla
|Jul 16, 2025
Post-Pandemic Dynamics of the Global Circulation of Human Metapneumovirus and Respiratory Syncytial Virus.Marie-Noëlle Billard, Joanne G Wildenbeest, Ruben Kole
|Apr 11, 2025
Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants.Ji-Man Kang, Xavier Carbonell-Estrany, Bosco Paes
|Feb 28, 2025
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in Canada.Élisabeth Mercier, John R Fullarton, Bosco A Paes
|Aug 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.Ian P Keary, Roberto Ravasio, John R Fullarton
Pageof 2
Frequent Collaborators
3 joint publications
Ian P Keary
3 joint publications
John R Fullarton
3 joint publications
Bosco Paes
2 joint publications
Xavier Carbonell-Estrany
1 joint publications
K Schmierer
1 joint publications
Marie-Noëlle Billard
1 joint publications
Louis Bont
1 joint publications
Paolo Manzoni
1 joint publications
Robert Delatolla
1 joint publications
Terho Heikkinen
